Drug intelligence / Profile preview

1-(3-hydroxypropyl)-2-[(3-nitrobenzoyl)amino]-1H-benzimidazol-5-yl pivalate

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the benzimidazole class. Its full chemical name is 1-(3-hydroxypropyl)-2-[ (3-nitrobenzoyl)amino ] -1H-benzimidazol -5 - yl pivalate. It has a molecular formula of C22H24N4O6 and a molecular weight of approximately 440.45 g/mol[6][4][7]. The structure features a benzimidazole core substituted with hydroxypropyl and nitrobenzoylamino groups and esterified with pivalic acid. There is no evidence that this compound has been approved for clinical use or that it has an established mechanism of action in humans; it appears to be an experimental or research chemical[6][7]. No information on its pharmacological activity, primary indication, or developer is available in public drug databases.

Other names
1-(3-hydroxypropyl)-2-(3-nitrobenzamido)-1,3-benzodiazol-5-yl 2,2-dimethylpropanoate[1-(3-hydroxypropyl)-2-{[(3-nitrophenyl)carbonyl]amino}-1H-benzimidazol-5-yl] 2,2-dimethylpropanoatePropanoic acid, 2,2-dimethyl-, 1-(3-hydroxypropyl)-2-[ (3-nitrobenzoyl)amino ] -1H-benzimidazol -5 - yl ester
02

Targets

IRAK1 (Interleukin-1 receptor-associated kinase 1)

Beyond the preview

Go deeper on 1-(3-hydroxypropyl)-2-[(3-nitrobenzoyl)amino]-1H-benzimidazol-5-yl pivalate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-(3-hydroxypropyl)-2-[(3-nitrobenzoyl)amino]-1H-benzimidazol-5-yl pivalate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call